Amarin soars on triglyceride-drug hopes By: MarketWatch April 18, 2011 at 14:31 PM EDT Shares of Amarin rally more than 90% after the release of better-than-expected study data for the company’s cardiovascular-disease drug AMR101. Read More >> Related Stocks: Abbott Laboratories Amarin Corp ADR Astrazeneca Plc ADR Gsk Plc ADR Merck & Co Pfizer Sanofi-Aventis S.A. ADR Valeant Pharmaceuticals International, Inc.